Searched for
REGULATORY APPROVALS IN INDIA
SME stock Yash Highvoltage shares soar over 12% after raising Rs 151 crore via preferential issueYash Highvoltage shares surged after the company approved a Rs 151 crore preferential issue to fund expansion. The capital will boost manuf...
India's asset wealth management AUM projected to reach US$ 1.7 trillion by 2030: PwC reportIndia’s asset and wealth management industry is projected to reach US$1.7 trillion in AUM by 2030, driven by rising retail participation, g...
Rs 1.5 lakh crore behind 2025! Can Jio, NSE and other mega IPOs put 2026 on course for another record year?India's primary market faces a significant fundraising gap to match last year's record. However, upcoming mega IPOs from Reliance Jio (Rs 3...
Mega IPO wave set to sweep Dalal Street as July listings gather paceIndia's IPO market is poised for a strong comeback in July, with over a dozen companies planning to raise approximately ₹45,000 crore. Majo...
Regulating charity without stifling it: The case for clearer rulesIndia's charity sector, vital for social needs, faces evolving regulations aimed at transparency. While scrutiny is accepted, current rules...
RBI says UPI-linked credit lines must follow same rules as traditional loans; Closes regulatory arbitrageThe Reserve Bank of India has mandated uniform prudential treatment for all credit facilities, including those disbursed via UPI. This move...
Syrma SGS Technology shares jump 5% after JV pact with Japan’s Kaga ElectronicsSyrma SGS Technology's shares jumped nearly 5% after announcing a significant joint venture with Japan's Kaga Electronics. This collaborati...
Stocks in news: TCS, JSW Infra, Craftsman Automation, IIFL Finance, Transrail LightingIndian markets showed a positive trend on Monday, recovering some of Friday's dips, buoyed by global sentiment and strong performance in th...
Affordable housing, rental expansion and RERA reforms set to define next growth phase in India's urban region: ReportIndia's housing sector is set for a major overhaul, driven by urbanization and policy shifts. A report highlights the urgent need for affor...
Bringing back open-market buybacks through stock exchanges is the right decisionSEBI’s decision to restore open-market buybacks through stock exchanges marks a pragmatic regulatory shift that supports efficient capital ...
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...
Sebi board meeting: Open market buyback is back and intraday borrowing for MFs; 5 key decisions investors should knowSebi approved a series of reforms to improve market efficiency and investor protection. Key changes include the return of exchange-based bu...
Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
SBI to raise Rs 60,000 cr in FY27 via bondsState Bank of India's board has approved raising up to Rs 60,000 crore in the current fiscal year through debt instruments. These funds wil...
Arunachal rolls out major deregulation drive to boost investmentArunachal Pradesh has significantly eased business regulations. The state has streamlined processes across 51 areas, including land, enviro...
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...